Developing an intestinal gel combination product

Swedish speciality pharmaceutical company, Lobsor Pharmaceutical AB, selected Recipharm to develop its recently approved Lecigon® gel for the treatment of advanced Parkinson’s disease (PD). 

Register below to download the full Case study.
/sites/default/files/media/CaseStudy_Developing-an-intestinal-gel-combination-product.pdf
False
True